Checchi Capital Advisers LLC lifted its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 17.0% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 7,331 shares of the pharmacy operator’s stock after buying an additional 1,063 shares during the quarter. Checchi Capital Advisers LLC’s holdings in Walgreens Boots Alliance were worth $534,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Asset Dedication LLC raised its stake in Walgreens Boots Alliance by 204.6% in the third quarter. Asset Dedication LLC now owns 1,578 shares of the pharmacy operator’s stock valued at $115,000 after purchasing an additional 1,060 shares in the last quarter. BlueMountain Capital Management LLC acquired a new position in Walgreens Boots Alliance in the second quarter valued at about $103,000. CSat Investment Advisory L.P. acquired a new position in Walgreens Boots Alliance in the second quarter valued at about $104,000. Squar Milner Financial Services LLC acquired a new position in Walgreens Boots Alliance in the second quarter valued at about $106,000. Finally, Kaizen Advisory LLC raised its stake in Walgreens Boots Alliance by 128.6% in the second quarter. Kaizen Advisory LLC now owns 1,925 shares of the pharmacy operator’s stock valued at $116,000 after purchasing an additional 1,083 shares in the last quarter. 64.81% of the stock is owned by institutional investors.
A number of research analysts recently commented on the company. Pivotal Research boosted their price target on Walgreens Boots Alliance from $60.00 to $72.00 and gave the company a “hold” rating in a research note on Monday, October 15th. Zacks Investment Research raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $79.00 price target for the company in a research note on Saturday, October 13th. Barclays boosted their price target on Walgreens Boots Alliance from $77.00 to $80.00 and gave the company an “equal weight” rating in a research note on Friday, October 12th. Robert W. Baird boosted their price target on Walgreens Boots Alliance from $69.00 to $71.00 and gave the company a “neutral” rating in a research note on Friday, October 12th. Finally, Citigroup boosted their price target on Walgreens Boots Alliance from $69.00 to $76.00 and gave the company a “neutral” rating in a research note on Friday, October 12th. One investment analyst has rated the stock with a sell rating, eleven have issued a hold rating, seven have issued a buy rating and two have issued a strong buy rating to the company’s stock. Walgreens Boots Alliance has an average rating of “Hold” and an average price target of $78.22.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Thursday, October 11th. The pharmacy operator reported $1.48 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.45 by $0.03. The firm had revenue of $33.44 billion during the quarter, compared to the consensus estimate of $33.64 billion. Walgreens Boots Alliance had a return on equity of 21.75% and a net margin of 3.82%. On average, sell-side analysts predict that Walgreens Boots Alliance Inc will post 6.53 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 12th. Shareholders of record on Monday, November 12th will be paid a dividend of $0.44 per share. This represents a $1.76 annualized dividend and a yield of 2.23%. The ex-dividend date of this dividend is Thursday, November 8th. Walgreens Boots Alliance’s payout ratio is 29.24%.
In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction dated Thursday, August 2nd. The stock was sold at an average price of $65.99, for a total transaction of $180,548.64. Following the completion of the transaction, the director now owns 10,943 shares of the company’s stock, valued at $722,128.57. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 14.80% of the stock is currently owned by insiders.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.
Featured Story: What are retained earnings?
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.